Literature DB >> 21153691

Dehydrosilybin attenuates the production of ROS in rat cardiomyocyte mitochondria with an uncoupler-like mechanism.

Eva Gabrielová1, Martin Jabůrek, Radek Gažák, Jitka Vostálová, Jan Ježek, Vladimír Křen, Martin Modrianský.   

Abstract

Reactive oxygen species (ROS) originating from mitochondria are perceived as a factor contributing to cell aging and means have been sought to attenuate ROS formation with the aim of extending the cell lifespan. Silybin and dehydrosilybin, two polyphenolic compounds, display a plethora of biological effects generally ascribed to their known antioxidant capacity. When investigating the cytoprotective effects of these two compounds in the primary cell cultures of neonatal rat cardiomyocytes, we noted the ability of dehydrosilybin to de-energize the cells by monitoring JC-1 fluorescence. Experiments evaluating oxygen consumption and membrane potential revealed that dehydrosilybin uncouples the respiration of isolated rat heart mitochondria albeit with a much lower potency than synthetic uncouplers. Furthermore, dehydrosilybin revealed a very high potency in suppressing ROS formation in isolated rat heart mitochondria with IC(50) = 0.15 μM. It is far more effective than its effect in a purely chemical system generating superoxide or in cells capable of oxidative burst, where the IC(50) for dehydrosilybin exceeds 50 μM. Dehydrosilybin also attenuated ROS formation caused by rotenone in the primary cultures of neonatal rat cardiomyocytes. We infer that the apparent uncoupler-like activity of dehydrosilybin is the basis of its ROS modulation effect in neonatal rat cardiomyocytes and leads us to propose a hypothesis on natural ischemia preconditioning by dietary polyphenols.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21153691     DOI: 10.1007/s10863-010-9319-2

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  35 in total

1.  NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance.

Authors:  Antonio Arroyo; Martin Modrianský; F Behice Serinkan; Rosario I Bello; Tatsuya Matsura; Jianfei Jiang; Vladimir A Tyurin; Yulia Y Tyurina; Bengt Fadeel; Valerian E Kagan
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

2.  Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation.

Authors:  F Paoletti; A Mocali
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 3.  Free radical biology and medicine: it's a gas, man!

Authors:  William A Pryor; Kendall N Houk; Christopher S Foote; Jon M Fukuto; Louis J Ignarro; Giuseppe L Squadrito; Kelvin J A Davies
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04-20       Impact factor: 3.619

Review 4.  Uncouple my heart: the benefits of inefficiency.

Authors:  Martin Modrianský; Eva Gabrielová
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

Review 5.  Cardioprotective signaling to mitochondria.

Authors:  Keith D Garlid; Alexandre D T Costa; Casey L Quinlan; Sandrine V Pierre; Pierre Dos Santos
Journal:  J Mol Cell Cardiol       Date:  2008-12-11       Impact factor: 5.000

6.  A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases.

Authors:  M Zhou; Z Diwu; N Panchuk-Voloshina; R P Haugland
Journal:  Anal Biochem       Date:  1997-11-15       Impact factor: 3.365

Review 7.  Mitochondria and reactive oxygen species.

Authors:  Alicia J Kowaltowski; Nadja C de Souza-Pinto; Roger F Castilho; Anibal E Vercesi
Journal:  Free Radic Biol Med       Date:  2009-05-08       Impact factor: 7.376

8.  Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study.

Authors:  Patrick Trouillas; Philippe Marsal; Alena Svobodová; Jitka Vostálová; Radek Gazák; Jan Hrbác; Petr Sedmera; Vladimír Kren; Roberto Lazzaroni; Jean-Luc Duroux; Daniela Walterová
Journal:  J Phys Chem A       Date:  2008-01-15       Impact factor: 2.781

9.  Multiple effects of silymarin on the hepatitis C virus lifecycle.

Authors:  Jessica Wagoner; Amina Negash; Olivia J Kane; Laura E Martinez; Yaakov Nahmias; Nigel Bourne; David M Owen; Joe Grove; Claire Brimacombe; Jane A McKeating; Eve-Isabelle Pécheur; Tyler N Graf; Nicholas H Oberlies; Volker Lohmann; Feng Cao; John E Tavis; Stephen J Polyak
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

10.  Targeting dinitrophenol to mitochondria: limitations to the development of a self-limiting mitochondrial protonophore.

Authors:  Frances H Blaikie; Stephanie E Brown; Linda M Samuelsson; Martin D Brand; Robin A J Smith; Michael P Murphy
Journal:  Biosci Rep       Date:  2006-06       Impact factor: 3.840

View more
  4 in total

Review 1.  Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives.

Authors:  Peter F Surai
Journal:  Antioxidants (Basel)       Date:  2015-03-20

Review 2.  Regulation of Mitochondrial Quality Control by Natural Drugs in the Treatment of Cardiovascular Diseases: Potential and Advantages.

Authors:  Xing Chang; Wenjin Zhang; Zhenyu Zhao; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Lei Zhang; Yuping Zhao
Journal:  Front Cell Dev Biol       Date:  2020-12-23

3.  Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart.

Authors:  Eva Gabrielová; Aleksey Vladimirovich Zholobenko; Lenka Bartošíková; Jiří Nečas; Martin Modriansky
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

4.  On the causes and consequences of the uncoupler-like effects of quercetin and dehydrosilybin in H9c2 cells.

Authors:  Aleksey V Zholobenko; Ange Mouithys-Mickalad; Zdenek Dostal; Didier Serteyn; Martin Modriansky
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.